PAINDURE
Founded in November 2009, Paindure is developing a biodegradable implant-based product enabling minimally invasive localized targeted therapy for treating migraine headaches. Treatment involves administering a long-term (6 months) local anesthetic. Prototype development can be completed within a 12-18 months period. Patents – provisional submitted on March 2009 regarding new use drug combination, new combination of formulation (slow release) and new administration.
PAINDURE
Industry:
Biotechnology Health Care Medical
Founded:
2009-11-01
Address:
Yamin, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.paindure.com
Status:
Closed
Contact:
972 8 655 8631
